Welborn, Jr., John Lee

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 40% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Welborn, Jr., John Lee's trades of HLS Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-08 2024-12-31
B Purchase
69,409 +21.1%
417.99
CA$686,837 		69,409 +21.1% 417.99 CA$686,837
2024-12-16 2024-12-12
B Purchase
24,222 -36.0%
85.09
CA$4,477,995 		24,222 -36.0% 85.09 CA$4,477,995
2023-06-12 2023-06-08
B Purchase
72,065
387.77
CA$738,618 		72,065 387.77 CA$738,618